Molecular pharmaceutics · 2025
Evaluation of Chinese Yam Polysaccharide-Aluminum Hydroxide Nanoparticle Combination Adjuvant for Porcine Circovirus Type 2 Vaccine and Underlying Mechanisms.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhao Qi, Zhang Ziye, Song Bowen, Zhang Jinglu, Li Yaao, Li Ziteng, Chen Hongyu, Xu Panpan, Zhu Yixuan, Yang Runyu, Zhao Xinghua, Shi Wanyu, Gu Pengfei
Аннотация
Conventional alum adjuvants primarily induce a Th2 humoral immune response yet fail to provoke a Th1 cellular immune response. In our preceding study, we constructed a novel and biosafe nanoparticle-based adjuvant system, in which the Chinese yam polysaccharide (CYP), as the immunopotentiator, was loaded onto aluminum hydroxide nanoparticles (CYP-AlNPs). Herein, we further investigated the adjuvant activity of the CYP-AlNPs against the porcine circovirus type 2 (PCV2) vaccine. Moreover, we further explored the underlying molecular mechanisms by which the CYP-AlNPs stimulated the dendritic cell (DC) activation. Our results demonstrated that the CYP-AlNPs exhibited good adjuvant activity as an adjuvant to the PCV2 vaccine, which elicited a robust antibody response, facilitated the generation of the germinal center in lymph nodes, increased the population of CD4+ and CD8+T cells, and enhanced the production of IFN-γ and IL-6, thereby inducing a mixed Th1 and Th2 immune response. Notably, our results revealed the crucial role of the NLRP3 inflammasome and TLR4-NF-κB signaling pathways in DC activation stimulated by the CYP-AlNPs. The present study highlighted the potential of polysaccharide-alum nanoparticle combination adjuvants that act through different mechanisms to achieve enhanced immune responses, providing a new perspective on vaccine design.